Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nexgel (NXGL) Cash & Equivalents (2019 - 2025)

Nexgel (NXGL) has disclosed Cash & Equivalents for 7 consecutive years, with $938000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Equivalents fell 11.43% year-over-year to $938000.0, compared with a TTM value of $938000.0 through Sep 2025, down 11.43%, and an annual FY2024 reading of $1.8 million, down 33.07% over the prior year.
  • Cash & Equivalents was $938000.0 for Q3 2025 at Nexgel, up from $725000.0 in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $13.4 million in Q4 2021 and bottomed at $382000.0 in Q2 2021.
  • Average Cash & Equivalents over 5 years is $2.8 million, with a median of $1.3 million recorded in 2021.
  • The sharpest move saw Cash & Equivalents skyrocketed 41618.75% in 2021, then tumbled 92.52% in 2023.
  • Year by year, Cash & Equivalents stood at $13.4 million in 2021, then plummeted by 91.75% to $1.1 million in 2022, then skyrocketed by 145.23% to $2.7 million in 2023, then plummeted by 33.07% to $1.8 million in 2024, then tumbled by 48.09% to $938000.0 in 2025.
  • Business Quant data shows Cash & Equivalents for NXGL at $938000.0 in Q3 2025, $725000.0 in Q2 2025, and $1.2 million in Q1 2025.